Back to top

Innoviva’s Nortiva Bio launches to develop long-acting oral medicines

Nortiva Bio “announced its launch as a clinical-stage biopharmaceutical company dedicated to developing long-acting oral medicines using its propri...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Innoviva, Inc. (INVA)